27/03/2015 04:14:57 Free Membership Login

Akers Biosciences Company Financial Information

 Company name: Akers Bio
 EPIC: AKR Trading Currency: GBX
 Market Sector: AIM ISIN: US00973E1029
 Market Segment: AIM Share Type: DE
 WWW Address: http://www.akersbiosciences.com/ Description: COM SHS NPV
 Industry Sector: HEALTH CARE EQUIPMENT & SERVICES
 Price Price Change [%] Bid Ask Open High Low Volume
 269.00 mages.advfn.com/imagesnew/2/us/dot 0.0 [0.00] 255.00 283.00 - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 14.00 5.20 -26.02 -44.36 - - - 315.00 - -

Akers Biosciences Key Figures

(at previous day's close)
Market Cap.14.00m
Shares In Issue5.20m
Prev. Close269.00
PE Ratio- 
Dividend Yield-%
EPS - basic-44.36p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-47.92p
Return On Equity (ROE)-21.23%
Operating Margin-70.64%
PEG Factor- 
EPS Growth Rate-%
Dividends PS Growth Rate-%
Net Debt0.89m
Gross Gearing11.07%
Quick Assets8.58m
Net Working Capital7.98m
Intangibles / Fixed Assets91.36%
Turnover PS54.62p
Pre-Tax Profit PS-38.58p
Retained Profit PS-38.77p
Cash PS5.62p
Net Cash PS-17.13p
Net Tangible Asset Value PS *155.83p
Net Asset Value PS182.67p
Spread28.00 (9.89%) 

Akers Biosciences Balance Sheet

LSE:AKR:Liabilities+EQLSE:AKR:Assets

Akers Biosciences Share Price

Sample Period HighLow
1 week271.50-
4 weeks271.50-
12 weeks271.50-
1 year315.00-

Akers Biosciences Share Price (5 years)

Akers Biosciences Historic Returns

Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week271.50-2.50-0.92270.000.00271.05
4 weeks242.5026.5010.93246.000.00255.65
12 weeks230.0039.0016.96247.840.00249.50
26 weeks270.00-1.00-0.37241.460.00242.28
1 year300.00-31.00-10.33253.260.00258.73
3 years123.75145.25117.37240.2232.34299.53
5 years2,025.00-1,756.00-86.72442.4832.49397.56

Akers Biosciences Key Management Ratios

Akers Biosciences Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 1.23 
Tobin's Q Ratio (excl. intangibles)1.55 
Dividend Yield-%
Market-to-Book Ratio1.47 
Price-to-Pre-Tax Profit PS-6.97 
Price-to-Retained Profit PS-6.94 
Price-to-Cash Flow PS-5.61 
Price-to-Sales PS4.93 
Price-to-Net Tangible Asset Value PS1.73 
Price-to-Cash PS47.83 
Net Working Capital PS153.29 
Price Pct to Working Capital PS1.75%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Akers Biosciences Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing8.34%
Net Gearing (excl. Intangibles)9.59%
Gross Gearing11.07%
Gross Gearing (excl. Intangibles)12.74%
Gearing Under 1 Year11.07%
Gearing Under 1 Year (excl. Intgbl)12.74%
Assets/Equity1.12 
Cash/Equity3.08 
(Liquidity Ratios)
Net Working Capital to Total Assets74.62%
Current Ratio7.74 
Quick Ratio (Acid Test)7.25 
Liquidity Ratio0.25 
Cash & Equiv/Current Assets3.19%
(Solvency Ratios)
Enterprise Value13.70m
CFO/Sales-0.88 
CFO/Attributable Profit- 
CFO/Assets-0.23 
CFO/Debt-2.11 
Total Debt/Equity Market Value0.08 
Total Debt/Sales0.42 
Total Debt/Pre-Tax Profit-0.59 
Total Debt1.18m
Total Debt/Net Current Assets0.15%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs4 
Beta (60-Mnth)Beta (36-Mnth)
-26.01752.0729
Alpha (60-Mnth)Alpha (36-Mnth)
2.38534.1101

Akers Biosciences Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-21.12%
Return On Assets (ROA)-17.76%
Net Profit Margin-70.99%
Assets Turnover0.25 
Return On Equity (ROE)-21.23%
Return On Investment (ROI)-21.32%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-70.99%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.30 
Fixed Assets Turnover1.12 
Current Assets Turnover0.32 
Net Working Capital Turnover 
Inventory Turnover2.94 
(Other Operating Ratios)
Total Assets-to-Sales4.00 
Debtors-to-Sales98.74%
Debt Collection Period360.40Days

Akers Biosciences Dividends

Sorry No Data Available

Akers Biosciences Fundamentals

 31 Dec 2011 (USD)31 Dec 2012 (USD)31 Dec 2013 (USD)31 Dec 2014 (USD)
turnover1.79100.00%1.52100.00%3.58100.00%4.43100.00%m
pre tax profit-3.88-217.48%-2.71-177.90%-1.53-42.67%-3.13-70.64%m
attributable profit-3.58-200.79%-2.54-166.90%-1.53-42.67%-3.14-70.99%m
retained profit-3.58-200.79%-2.54-166.90%-1.53-42.67%-3.14-70.99%m
eps - basic-2.00 -1.00 -96.00 -66.00 
eps - diluted-2.00 -1.00 -96.00 -66.00 
dividends per share- - - - 

Akers Biosciences Balance Sheet

 31 Dec 2011 (USD)31 Dec 2012 (USD)31 Dec 2013 (USD)31 Dec 2014 (USD)
LSE:AKR:Liabilities+EQLSE:AKR:AssetsLSE:AKR:Liabilities+EQLSE:AKR:AssetsLSE:AKR:Liabilities+EQLSE:AKR:AssetsLSE:AKR:Liabilities+EQLSE:AKR:Assets
 31 Dec 2011 (USD)31 Dec 2012 (USD)31 Dec 2013 (USD)31 Dec 2014 (USD)
ASSETS
fixed assets fixed assets0.344.96%0.243.74%0.274.40%0.201.21%m
intangibles intangibles3.9357.16%3.6957.55%2.4340.07%2.1813.07%m
fixed investments fixed investments0.000.07%0.000.07%0.000.07%0.000.03%m
current assets - other current assets - other0.081.23%0.071.06%0.162.70%9.3756.29%m
stocks stocks0.699.96%0.9915.39%1.0316.87%0.915.44%m
debtors debtors0.649.29%0.7912.32%2.0834.18%3.5421.23%m
cash & securities cash & securities1.1917.33%0.639.86%0.101.71%0.462.74%m
TOTAL6.88100%6.42100%6.08100%16.65100%m
LIABILITIES
creditors - short creditors - short0.7110.38%2.1132.93%1.9532.15%1.8411.07%m
creditors - long creditors - long--%--%--%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL0.7110.38%2.1132.93%1.9532.15%1.8411.07%m
EQUITY
ord cap, reserves ord cap, reserves6.1789.62%4.3067.07%4.1267.85%14.8188.93%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL6.1789.62%4.3067.07%4.1267.85%14.8188.93%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Akers Biosciences Cash Flow Statement

31 Dec 2011 (USD)31 Dec 2012 (USD)31 Dec 2013 (USD)31 Dec 2014 (USD)
Operating CF-2.26-0.82-2.73-3.88m
Pre-Financing CF-2.51-1.01-2.66-13.17m
Retained CF0.77-0.56-0.530.35m

Akers Biosciences Brokers

NameActivityTypeMnemonicCode
Arbuthnot Securities LimitedMarket Maker(MMF)Broker/DealerARBTALESGB31MKT
Commerzbank AGMarket Maker(MMF)Broker/DealerKLWTDRESGB2LPST
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Jefferies International LtdMarket Maker(MMF)Broker/DealerJEFFJEFFGB2X
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us lse akr150327 04:14